Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 732413, 20 pages
http://dx.doi.org/10.1155/2011/732413
Review Article

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

1Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
2Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Received 1 July 2011; Accepted 24 October 2011

Academic Editor: Michael H. Kershaw

Copyright © 2011 Christopher Jackson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [74 citations]

The following is the list of published articles that have cited the current article.

  • Lisheng Ge, Andrew N. Cornforth, Neil T. Hoa, Christina Delgado, Shiun Kwei Chiou, Yi Hong Zhou, and Martin R. Jadus, “Differential Glioma-Associated Tumor Antigen Expression Profiles of Human Glioma Cells Grown in Hypoxia,” PLoS ONE, vol. 7, no. 9, 2012. View at Publisher · View at Google Scholar
  • Brendan Fong, Richard Jin, Xiaoyan Wang, Michael Safaee, Dominique N. Lisiero, Isaac Yang, Gang Li, Linda M. Liau, and Robert M. Prins, “Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients,” Plos One, vol. 7, no. 4, 2012. View at Publisher · View at Google Scholar
  • Laura K. Aguilar, Mariel Arvizu, Estuardo Aguilar-Cordova, and E. Antonio Chiocca, “The Spectrum of Vaccine Therapies for Patients With Glioblastoma Multiforme,” Current Treatment Options in Oncology, vol. 13, no. 4, pp. 437–450, 2012. View at Publisher · View at Google Scholar
  • Sergiy V. Kushchayev, Yevgeniya S. Kushchayeva, Philip C. Wiener, Adrienne C. Scheck, Behnam Badie, and Mark C. Preul, “Monocyte-Derived Cells of the Brain and Malignant Gliomas: The Double Face of Janus,” World Neurosurgery, 2012. View at Publisher · View at Google Scholar
  • Tiffany Doucette, Ganesh Rao, Arvind Rao, Li Shen, Kenneth Aldape, Jun Wei, Kristine Dziurzynski, Mark Gilbert, and Amy B. Heimberger, “Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas,” Cancer Immunology Research, vol. 1, no. 2, pp. 112–122, 2013. View at Publisher · View at Google Scholar
  • Zaitun Zakaria, Eoin Fenton, Ayman Khalil, Muhammad Taufiq Sattar, and Peter Molnar, “Stupp-treated glioblastoma accompanied by EBV-positive primary CNS lymphoma,” British Journal of Neurosurgery, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • N. Sintupisut, P.-L. Liu, and C.-H. Yeang, “An integrative characterization of recurrent molecular aberrations in glioblastoma genomes,” Nucleic Acids Research, 2013. View at Publisher · View at Google Scholar
  • David A Reardon, Kai W Wucherpfennig, Gordon Freeman, Catherine J Wu, E Antonio Chiocca, Patrick Y Wen, William T Curry, Duane A Mitchell, Peter E Fecci, John H Sampson, and Glenn Dranoff, “An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma,” Expert Review of Vaccines, vol. 12, no. 6, pp. 597–615, 2013. View at Publisher · View at Google Scholar
  • Brian M Alexander, Eudocia Q Lee, David A Reardon, and Patrick Y Wen, “Current and future directions for Phase II trials in high-grade glioma,” Expert Review of Neurotherapeutics, vol. 13, no. 4, pp. 369–387, 2013. View at Publisher · View at Google Scholar
  • Ge Zhang, Li Zhang, Huafei Li, Hao Wang, Geng Kou, Jie Gao, Mengxin Zhao, Shangjing Guo, Yajun Guo, Bohua Li, Jianxin Dai, Wei Li, and Huafeng Wei, “The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy,” Mini-Reviews In Medicinal Chemistry, vol. 13, no. 5, pp. 643–652, 2013. View at Publisher · View at Google Scholar
  • Andrea M. Murphy, and Samuel D. Rabkin, “Current status of gene therapy for brain tumors,” Translational Research, vol. 161, no. 4, pp. 339–354, 2013. View at Publisher · View at Google Scholar
  • Ryuichi Kanai, and Samuel D Rabkin, “Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors,” CNS Oncology, vol. 2, no. 2, pp. 129–142, 2013. View at Publisher · View at Google Scholar
  • Christopher Jackson, Jacob Ruzevick, Henry Brem, and Michael Lim, “Vaccine strategies for glioblastoma: progress and future directions,” Immunotherapy, vol. 5, no. 2, pp. 155–167, 2013. View at Publisher · View at Google Scholar
  • Kerrie Leanne McDonald, “Current Progress for the Use of miRNAs in Glioblastoma Treatment,” Molecular Neurobiology, vol. 48, no. 3, pp. 757–768, 2013. View at Publisher · View at Google Scholar
  • Yanshan Zhang, Yunyi Yao, Huijuan Wang, Yanqin Guo, Hui Zhang, and Liang Chen, “Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment,” Chinese Journal of Cancer Research, vol. 25, no. 5, pp. 520–526, 2013. View at Publisher · View at Google Scholar
  • Sarah Nicholas, Dimitris Mathios, Jacob Ruzevick, Christopher Jackson, Isaac Yang, and Michael Lim, “Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors,” Brain Tumor Research and Treatment, vol. 1, no. 1, pp. 2, 2013. View at Publisher · View at Google Scholar
  • Carl Friedrich Classen, “Glioblastomas: are individual therapies required for individual tumors?,” journal of Cancer Therapeutics and Research, vol. 2, no. 1, pp. 17, 2013. View at Publisher · View at Google Scholar
  • Jun-Xia Cao, Xiao-Yan Zhang, Jin-Long Liu, Duo Li, Jun-Li Li, Yi-Shan Liu, Min Wang, Bei-Lei Xu, Hai-Bo Wang, and Zheng-Xu Wang, “Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Eli T. Sayegh, Taemin Oh, Shayan Fakurnejad, Orin Bloch, and Andrew T. Parsa, “Vaccine therapies for patients with glioblastoma,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Zineb Belcaid, Jillian A. Phallen, Jing Zeng, Alfred P. See, Dimitrios Mathios, Chelsea Gottschalk, Sarah Nicholas, Meghan Kellett, Jacob Ruzevick, Christopher Jackson, Emilia Albesiano, Nicholas M. Durham, Xiaobu Ye, Phuoc T. Tran, Betty Tyler, John W. Wong, Henry Brem, Drew M. Pardoll, Charles G. Drake, and Michael Lim, “Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model,” Plos One, vol. 9, no. 7, 2014. View at Publisher · View at Google Scholar
  • Hiroshi Yano, Archana Thakur, Elyse N. Tomaszewski, Minsig Choi, Abhinav Deol, and Lawrence G. Lum, “Ipilimumab augments antitumor activity of bispecific antibody-armed T cells,” Journal of Translational Medicine, vol. 12, 2014. View at Publisher · View at Google Scholar
  • Adam M Swartz, Qi-Jing Li, and John H Sampson, “Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme,” Immunotherapy, vol. 6, no. 6, pp. 679–690, 2014. View at Publisher · View at Google Scholar
  • Richard G. Everson, Michael Safaee, Rudi Scharnweber, Dominique N. Lisiero, Robert M. Prins, Richard M. Jin, Xiaoyan Wang, Horacio Soto, and Linda M. Liau, “Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients,” Journal for ImmunoTherapy of Cancer, vol. 2, no. 1, 2014. View at Publisher · View at Google Scholar
  • Jeffrey J. Olson, Lakshmi Nayak, D. Ryan Ormond, Patrick Y. Wen, Steven N. Kalkanis, and Timothy Charles Ryken, “The role of targeted therapies in the management of progressive glioblastoma,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Claudia Bello, Dania Vazquez-Blomquist, Jamilet Miranda, Yanelda Garcia, Lidia Ines Novoa, Daniel Palenzuela, and Iraldo Bello, “Regulation by IFN-alpha/IFN-gamma Co-Formulation (HerberPAG (R)) of Genes Involved in Interferon-STAT-Pathways and Apoptosis in U87MG,” Current Topics in Medicinal Chemistry, vol. 14, no. 3, pp. 351–358, 2014. View at Publisher · View at Google Scholar
  • Sara Pedron, Eftalda Becka, and Brendan A. Harley, “Spatially Gradated Hydrogel Platform as a 3D Engineered Tumor Microenvironment,” Advanced Materials, 2014. View at Publisher · View at Google Scholar
  • Astrid Authier, Kathryn J. Farrand, Kate W.R. Broadley, Lindsay R. Ancelet, Martin K. Hunn, Sarrabeth Stone, Melanie J. McConnell, and Ian F. Hermans, “Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Taemin Oh, Eli T. Sayegh, Shayan Fakurnejad, Daniel Oyon, Jonathan Balquiedra Lamano, Joseph David DiDomenico, Orin Bloch, and Andrew T. Parsa, “Vaccine Therapies in Malignant Glioma,” Current Neurology and Neuroscience Reports, vol. 15, no. 1, 2014. View at Publisher · View at Google Scholar
  • David A. Reardon, Gordon Freeman, Catherine Wu, E. Antonio Chiocca, Kai W. Wucherpfennig, Patrick Y. Wen, Edward F. Fritsch, William T. Curry, John H. Sampson, and Glenn Dranoff, “Immunotherapy advances for glioblastoma,” Neuro-Oncology, vol. 16, no. 11, pp. 1441–1458, 2014. View at Publisher · View at Google Scholar
  • Wei Li, Huafeng Wei, Huafei Li, Jie Gao, Si-Shen Feng, and Yajun Guo, “Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology,” Nanomedicine, vol. 9, no. 16, pp. 2587–2605, 2014. View at Publisher · View at Google Scholar
  • Stephen Yiu Chuen Choi, Dong Lin, Peter W. Gout, Colin C. Collins, Yong Xu, and Yuzhuo Wang, “Lessons from patient-derived xenografts for better in vitro modeling of human cancer,” Advanced Drug Delivery Reviews, 2014. View at Publisher · View at Google Scholar
  • Dimitrios Mathios, Jacob Ruzevick, Christopher M. Jackson, Haiying Xu, Sagar Shah, Janis M. Taube, Peter C. Burger, Edward F. McCarthy, Alfredo Quinones-Hinojosa, Drew M. Pardoll, and Michael Lim, “PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Matthias Preusser, Michael Lim, David A. Hafler, David A. Reardon, and John H. Sampson, “Prospects of immune checkpoint modulators in the treatment of glioblastoma,” Nature Reviews Neurology, 2015. View at Publisher · View at Google Scholar
  • Tej D. Azad, Seyed-Mostafa Razavi, Benjamin Jin, Karen Lee, and Gordon Li, “Glioblastoma antigen discovery—foundations for immunotherapy,” Journal of Neuro-Oncology, 2015. View at Publisher · View at Google Scholar
  • M. Lim, “Immunotherapy for glioblastoma: are we finally getting closer?,” Neuro-Oncology, 2015. View at Publisher · View at Google Scholar
  • J. Yan, L.-Y. Kong, J. Hu, K. Gabrusiewicz, D. Dibra, X. Xia, A. B. Heimberger, and S. Li, “FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas,” JNCI Journal of the National Cancer Institute, vol. 107, no. 8, pp. djv137–djv137, 2015. View at Publisher · View at Google Scholar
  • Kevin K. H. Chow, Wendy Hara, Michael Lim, and Gordon Li, “Combining immunotherapy with radiation for the treatment of glioblastoma,” Journal of Neuro-Oncology, 2015. View at Publisher · View at Google Scholar
  • Rogelio Esparza, Tej D. Azad, Abdullah H. Feroze, Siddhartha S. Mitra, and Samuel H. Cheshier, “Glioblastoma stem cells and stem cell-targeting immunotherapies,” Journal of Neuro-Oncology, 2015. View at Publisher · View at Google Scholar
  • Mélanie Morin-Brureau, Kirsten M. Hooper, Michael Prosniak, Sami Sauma, Larry A. Harshyne, David W. Andrews, and D. Craig Hooper, “Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide,” Cancer Immunology, Immunotherapy, 2015. View at Publisher · View at Google Scholar
  • Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, Maximilian Mehdorn, Dirk Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim G. Hartung, Dirk Reuter, Monika Warmuth Metz, Ferdinand Bach, and Torsten Pietsch, “A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma,” European Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Revaz Machaidze, Milota Kaluzova, Alexandros Bouras, and Costas G. Hadjipanayis, “Targeted therapy of glioblastoma stem-like cells and tumor nonstem cells using cetuximab-conjugated iron-oxide nanoparticles,” Oncotarget, vol. 6, no. 11, pp. 8788–8806, 2015. View at Publisher · View at Google Scholar
  • Runze Yang, Susobhan Sarkar, Daniel J. Korchinski, Ying Wu, V. Wee. Yong, and Jeff F. Dunn, “MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor,” Neuro-Oncology, pp. now180, 2016. View at Publisher · View at Google Scholar
  • Neha Kamran, Alexandra Calinescu, Marianela Candolfi, Mayuri Chandran, Yohei Mineharu, Antonela S. Asad, Carl Koschmann, Felipe J. Nunez, Pedro R. Lowenstein, and Maria G. Castro, “Recent advances and future of immunotherapy for glioblastoma,” Expert Opinion on Biological Therapy, pp. 1–20, 2016. View at Publisher · View at Google Scholar
  • Tiffany R Hodges, Sherise D Ferguson, and Amy B Heimberger, “Immunotherapy in glioblastoma: emerging options in precision medicine,” CNS Oncology, 2016. View at Publisher · View at Google Scholar
  • Dimitrios Mathios, Sarah Harris-Bookman, Xiaobu Ye, Vladimir Coric, Mark Selby, Charles G. Drake, Michael Lim, Debebe Theodros, Brian Francica, Mira A. Patel, Christopher C. Jackson, Christina Jackson, Phuoc T. Tran, Betty Tyler, Henry Brem, Jennifer E. Kim, Drew M. Pardoll, Ada Tam, Esteban Velarde, Christina M. Kochel, Thomas R. Nirschl, and Ali Ghasemzadeh, “Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma,” Journal for ImmunoTherapy of Cancer, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • Seyed-Mostafa Razavi, Karen E. Lee, Benjamin E. Jin, Parvir S. Aujla, Sharareh Gholamin, and Gordon Li, “Immune Evasion Strategies of Glioblastoma,” Frontiers in Surgery, vol. 3, 2016. View at Publisher · View at Google Scholar
  • Paul R. Gielen, Barbara M. Schulte, Esther D. Kers-Rebel, Kiek Verrijp, Sandra A.J.F.H. Bossman, Mark ter Laan, Pieter Wesseling, and Gosse J. Adema, “Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function,” Neuro-Oncology, pp. now034, 2016. View at Publisher · View at Google Scholar
  • Or Cohen-Inbar, and Menashe Zaaroor, “Immunological Aspects of Malignant Gliomas,” Canadian Journal of Neurological Sciences, vol. 43, no. 4, pp. 494–502, 2016. View at Publisher · View at Google Scholar
  • Kristen Haberthur, Kathryn Brennan, Virginia Hoglund, Stephanie Balcaitis, Harrison Chinn, Amira Davis, Shannon Kreuser, Conrad Winter, Sarah E.S. Leary, Gail H. Deutsch, Richard G. Ellenbogen, and Courtney A. Crane, “NKG2D ligand expression in pediatric brain tumors,” Cancer Biology & Therapy, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Stefan-Alexandru Artene, Anica Dricu, Adina Turcu-Stiolica, Marius Eugen Ciurea, Oana Alexandru, Ligia Gabriela Tataranu, Richard Hartley, Oana Daianu, Corina Brindusa, and Stefana Oana Purcaru, “Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: A survival gain analysis,” OncoTargets and Therapy, vol. 9, pp. 6669–6677, 2016. View at Publisher · View at Google Scholar
  • S. Pedron, H. Polishetty, A.M. Pritchard, B.P. Mahadik, J.N. Sarkaria, and B.A.C. Harley, “Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics,” MRS Communications, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Gina Li, Nicolas Bonamici, Mahua Dey, Maciej S. Lesniak, and Irina V. Balyasnikova, “Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies,” Expert Opinion on Drug Delivery, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Jun Yang, Yan-Qin Shen, Jie Weng, Chenmeng Qiao, Qi Shen, and Xin Zhang, “RNA interference-based immunomodulation for glioblastoma immune microenvironment: A review,” Journal of Biomedical Nanotechnology, vol. 13, no. 8, pp. 891–910, 2017. View at Publisher · View at Google Scholar
  • Gustavo Ignacio Vázquez Cervantes, Nora Karen Olascoaga Arellano, Daniela Ramírez Ortega, Alelí Salazar Ramiro, Dinora F. González Esquivel, Camilo Ríos, Benjamín Pineda Olvera, and Verónica Pérez de la Cruz, “Role of Kynurenine Pathway in Glioblastoma,” Mechanisms of Neuroinflammation, 2017. View at Publisher · View at Google Scholar
  • Ravi Kumar, Tristan de Mooij, Timothy E. Peterson, Tatiana Kaptzan, Aaron J. Johnson, David J. Daniels, and Ian F. Parney, “Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane,” Plos One, vol. 12, no. 6, pp. e0179012, 2017. View at Publisher · View at Google Scholar
  • Tamara J. Abou-Antoun, James S. Hale, Justin D. Lathia, and Stephen M. Dombrowski, “Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications,” Neurotherapeutics, 2017. View at Publisher · View at Google Scholar
  • Singleton, Gill, Collins, Bienemann, Killick-Cole, Butts, Wyatt, Barua, Haynes, and Asby, “Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model,” International Journal of Nanomedicine, vol. 12, pp. 1385–1399, 2017. View at Publisher · View at Google Scholar
  • Soliman Oushy, Justin E. Hellwinkel, Mary Wang, Ger J. Nguyen, Dicle Gunaydin, Tessa A. Harland, Thomas J. Anchordoquy, and Michael W. Graner, “Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 373, no. 1737, pp. 20160477, 2017. View at Publisher · View at Google Scholar
  • Boyuan Huang, Hongbo Zhang, Lijuan Gu, Bainxin Ye, Zhihong Jian, Creed Stary, and Xiaoxing Xiong, “Advances in Immunotherapy for Glioblastoma Multiforme,” Journal of Immunology Research, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • K.A. Riccione, P. Gedeon, L. Sanchez-Perez, and J.H. Sampson, “Checkpoint Blockade Immunotherapy for Glioblastoma,” Translational Immunotherapy of Brain Tumors, pp. 261–300, 2017. View at Publisher · View at Google Scholar
  • Feng Yu, Sajid Asghar, Mei Zhang, Jingwei Zhang, Qineng Ping, and Yanyu Xiao, “Local strategies and delivery systems for the treatment of malignant gliomas,” Journal of Drug Targeting, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Martina Da Ros, Veronica De Gregorio, Anna Iorio, Laura Giunti, Milena Guidi, Maurizio de Martino, Lorenzo Genitori, and Iacopo Sardi, “Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier,” International Journal of Molecular Sciences, vol. 19, no. 10, pp. 2879, 2018. View at Publisher · View at Google Scholar
  • Diana Matias, Joana Balça-Silva, Grazielle C. da Graça, Caroline M. Wanjiru, Lucy W. Macharia, Carla Pires Nascimento, Natalia R. Roque, Juliana M. Coelho-Aguiar, Cláudia M. Pereira, Marcos F. Dos Santos, Luciana S. Pessoa, Flavia R. S. Lima, Alberto Schanaider, Valéria P. Ferrer, and Vivaldo Moura-Neto, “Microglia/Astrocytes–Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors,” Frontiers in Cellular Neuroscience, vol. 12, 2018. View at Publisher · View at Google Scholar
  • Jee-Wei E. Chen, Sara Pedron, Peter Shyu, Yuhang Hu, Jann N. Sarkaria, and Brendan A. C. Harley, “Influence of Hyaluronic Acid Transitions in Tumor Microenvironment on Glioblastoma Malignancy and Invasive Behavior,” Frontiers in Materials, vol. 5, 2018. View at Publisher · View at Google Scholar
  • Shariq S. Khwaja, Chunyu Cai, Shahed N. Badiyan, Xiaowei Wang, and Jiayi Huang, “The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence,” Oncotarget, vol. 9, no. 49, pp. 29036–29046, 2018. View at Publisher · View at Google Scholar
  • Nivedita M Ratnam, Mark R Gilbert, and Amber J Giles, “Immunotherapy in CNS cancers: the role of immune cell trafficking,” Neuro-Oncology, 2018. View at Publisher · View at Google Scholar
  • Meghan Logun, Wujun Zhao, Leidong Mao, and Lohitash Karumbaiah, “Microfluidics in Malignant Glioma Research and Precision Medicine,” Advanced Biosystems, pp. 1700221, 2018. View at Publisher · View at Google Scholar
  • Tomas Garzon-Muvdi, Henry Brem, Drew M. Pardoll, Debebe Theodros, Andrew S. Luksik, Russell Maxwell, Eileen Kim, Christopher M. Jackson, Sudipto Ganguly, Michael Lim, Zineb Belcaid, and Betty Tyler, “Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma,” Oncotarget, vol. 9, no. 29, pp. 20681–20697, 2018. View at Publisher · View at Google Scholar
  • Xin Cui, Renee-Tyler Tan Morales, Weiyi Qian, Haoyu Wang, Jean-Pierre Gagner, Igor Dolgalev, Dimitris Placantonakis, David Zagzag, Luisa Cimmino, Matija Snuderl, Raymond H.W. Lam, and Weiqiang Chen, “Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis,” Biomaterials, 2018. View at Publisher · View at Google Scholar
  • Nicholas F. Brown, Thomas J. Carter, Diego Ottaviani, and Paul Mulholland, “Harnessing the immune system in glioblastoma,” British Journal of Cancer, 2018. View at Publisher · View at Google Scholar
  • Jinquan Cai, Qun Chen, Yuqiong Cui, Jiawei Dong, Meng Chen, Pengfei Wu, and Chuanlu Jiang, “Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples,” OncoImmunology, pp. 00–00, 2018. View at Publisher · View at Google Scholar
  • Sara Pedron, Gabrielle L. Wolter, Jee-Wei E. Chen, Sarah E. Laken, Jann N. Sarkaria, and Brendan A.C. Harley, “Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens,” Biomaterials, pp. 119371, 2019. View at Publisher · View at Google Scholar
  • Rajan Patel, Jeffrey I. Traylor, Khatri Latha, Amy B. Heimberger, Shulin Li, and Ganesh Rao, “Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment,” Expert Opinion on Therapeutic Targets, pp. 1–3, 2019. View at Publisher · View at Google Scholar
  • Lawrence Kleinberg, Lindsey Sloan, Stuart Grossman, and Michael Lim, “Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy,” Neurosurgery, 2019. View at Publisher · View at Google Scholar